MAGEA3 and cancer: Another study developed a multi-epitope vaccine targeting important cancer antigens like STAT3, HER2, and GRB7 using a multimodal strategy that included MHC I, MHC II, CTL, and B-cell epitopes created from MAGE-A3, EGF, and MUC-1 by in silico immunoinformatics techniques.